## CHD: Church & Dwight Company, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -3.5% below STRENGTH zone (4.0-10.0%); PEG 1.88 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($79.29)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Church & Dwight Co., Inc. $CHD Stock Holdings Increased by 1832 Asset Management L.P.**
- Source: MarketBeat | 20251207T081522 | Somewhat-Bullish | Relevance: 99%
-  1832 Asset Management L.P. significantly increased its stake in Church & Dwight Co., Inc. (NYSE:CHD) by 275.1% during the second quarter, now owning 21,498 shares valued at approximately $2.066 million. Other institutional investors have also adjusted their holdings, with 86.60% of the stock currently owned by institutions and hedge funds. Church & Dwight recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend.

**2. Church & Dwight to sell VitaFusion and L’il Critters brands to Piping Rock**
- Source: Investing.com | 20251209T220911 | Somewhat-Bullish | Relevance: 99%
-  Church & Dwight Co., Inc. (NYSE:CHD) announced the sale of its VitaFusion and L’il Critters vitamin brands to Piping Rock Health Products, Inc. This transaction, expected to close before the end of 2025, follows a strategic review of Church & Dwight's vitamin, minerals, and supplement business, which represents less than 5% of their anticipated 2025 net sales. The company expects an after-tax charge of $40 million to $45 million in Q4 2025 related to the deal.

**3. How Is Church & Dwight's Stock Performance Compared to Other Consumer Staples Stocks?**
- Source: inkl | 20251209T090759 | Neutral | Relevance: 98%
- Church & Dwight (CHD) stock has underperformed significantly compared to the broader Consumer Staples Select Sector SPDR Fund (XLP) over the past three months, year-to-date, and the last 52 weeks. Despite a post-Q3 earnings surge due to better-than-expected results, the stock reflects a bearish trend, trading below its moving averages. Analysts, however, rate CHD as a "Moderate Buy" with a substantial upside potential.

**4. Church & Dwight (NYSE: CHD) to divest VitaFusion and L’il Critters VMS brands**
- Source: Stock Titan | 20251209T214734 | Neutral | Relevance: 98%
-  Church & Dwight Co., Inc. (NYSE: CHD) has entered into a definitive agreement to sell its VitaFusion® and L’il Critters® brands. This divestiture follows a strategic review of the company's vitamins, minerals and supplements (VMS) business and includes related trademarks, licenses, and manufacturing/distribution facilities in Vancouver and Ridgefield, Washington. The transaction is expected to close before year-end, subject to customary closing conditions.

**5. Church & Dwight to Sell VitaFusion and L’il Critters Brands**
- Source: Business Wire | 20251209T213134 | Somewhat-Bullish | Relevance: 98%
- Church & Dwight Co., Inc. (NYSE:CHD) has announced a definitive agreement to sell its VitaFusion® and L’il Critters® vitamin brands to Piping Rock Health Products, Inc. This transaction, expected to close by the end of 2025, includes manufacturing facilities and is anticipated to streamline Church & Dwight's portfolio. The sale will result in a one-time, after-tax charge of $40 million to $45 million for Church & Dwight in the fourth quarter of 2025.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Argus Research | $102 | $110 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 18 ($0.04M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-2.1%)
- Blackrock Inc.: 9.3% (-1.1%)
- State Street Corpora: 5.7% (+2.4%)
- JPMORGAN CHASE & CO: 5.1% (+105.9%)
- Capital Internationa: 4.0% (+0.5%)

### Key Risks

1. Long-term trend broken: trading 13.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.88 elevated, pricing in significant growth expectations. Forward P/E 22.0x stretched relative to 8% growth. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.1B |
| Beta | 0.45 |
| 52W Range | $81.33 - $116.46 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.88 |
| Forward P/E | 22.0 |
| Current P/E | 23.7 |
| YoY Growth | 7.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -2.4% to -3.5% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.5pp (needs >4.0% for momentum thesis). Below SMA200 (0.87x), long-term trend not supportive. RSI neutral at 43.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.53% (CS: 30) | Weak |
| RSI_14 | 42.6 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 0.985x | Below |
| vs SMA50 | 0.965x | Below |
| vs SMA200 | 0.868x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $82.63
- **Stop Loss:** $79.29 (4.0% risk)
- **Target:** $85.97 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 149
- **Position Value:** $12,311.87
- **Portfolio %:** 12.31%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-30 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.74 | $0.81 | +9.9% |
| 2025Q2 | $0.86 | $0.94 | +9.5% |
| 2025Q1 | $0.90 | $0.91 | +1.4% |
| 2024Q4 | $0.77 | $0.77 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*